Stay ahead of rapidly changing global cybersecurity requirements for medical devices. This two-day interactive workshop will provide regulatory, quality, and technical professionals with the tools and knowledge needed to address cybersecurity risks, strengthen regulatory submissions, and meet expectations from health authorities worldwide that you can apply immediately.
Cybersecurity remains mission-critical for medical device manufacturers. As regulatory expectations, threats, and technologies continue to evolve, organizations must stay current with the latest approaches to securing devices and supporting regulatory submissions.
Securing medical devices and documents for regulatory submissions from cyberattacks is challenging. Many medical device companies struggle to retrofit their security programs to address hardening, vulnerability management, and global incident response. New statutory requirements in the United States are increasing the focus on planned postmarket activities in the submission process.
Health authorities spanning the US, European Union, Australia, Canada, and Japan have issued cybersecurity guidance that is essential for regulatory affairs professionals to understand. In addition to premarket concerns, some of the guidance also includes expectations for post-market expectations.
This timely interactive virtual workshop will help regulatory and quality professionals develop the knowledge they need to help steer their organizations in the right direction when it comes to global cybersecurity expectations.
Technical staff will get a better understanding of how to translate regulatory expectations into concrete design and development. Organizational leaders will gain strategic knowledge that will increase the likelihood of gaining green lights from regulators while also teaching them how to establish trust with customers concerned about risk related to medical devices on their networks.
Upon completion of this two-day workshop, attendees will:
Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.
This event will be happening on 13 October and 15 October 2026 from 9-5 pm
An Introduction to Medical Device Cybersecurity Concepts and Challenges
Speaker: Michelle Jump
Medical Device Product Security Programs: Putting together the puzzle
Speaker: Michelle Jump
FDA’s 2023 Guidance and Policy Update
Speaker: Matthew Hazelett
FDA Select Update, 524B, and Omnibus
Speaker: Matthew Hazelett
eSTAR: Review of the Document Expectations
Speaker: Michelle Jump
Secure Design: You Can’t Mitigate Your Way to Security
Speaker: Matthew Hazelett
SBOM
Speaker: Michelle Jump
Security Risk Management and Threat Modeling
Speaker: Michelle Jump
Submission Strategies for Cybersecurity
Speaker: Matthew Hazelett
IEC 81001-5-1: Foundational Standard for Cybersecurity
Speaker: Michelle Jump
Labeling and Communication
Speaker: Michelle Jump
Overview of global regulatory expectations
Speaker: Michelle Jump
Postmarket Overview
Speaker: Michelle Jump
Threat Intelligence and Incident Response
Speaker: Michelle Jump
Vulnerability and Patch Management
Speaker: Michelle Jump
Disclosure and Advisory: When and How
Speaker: Michelle Jump
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


Chief Operating Officer and Chief Quality Officer (Former FDA Cybersecurity Policy Analyst), MedSec

CEO, MedSec
Michelle Jump is the CEO of MedSec, where she is responsible for providing strategic leadership, training, and advisory services to the medical device industry in the area of cybersecurity compliance, global regulations, standards, product security program development, and security risk management.
Chief Operating Officer and Chief Quality Officer (Former FDA Cybersecurity Policy Analyst), MedSec
Matthew Hazelett is a former cybersecurity policy analyst at the US Food and Drug Administration Center for Devices and Radiological Health Office of Product Evaluation and Quality Clinical and Scientific Policy. Hazelett started at the FDA as a biomedical engineer within the Implantable Electrophysiology Devices Branch at the Center for Devices and Radiological Health (CDRH). His review areas include pacemakers, defibrillators, leads, and supporting devices, such as programmers and home monitors. Since starting at FDA, Hazelett developed a review focus on cybersecurity, participates in cybersecurity guidance development, and supports cybersecurity vulnerability assessments and reviews across CDRH. Hazelett also has worked for a medical device research and development company as a test engineer and test manager overseeing device verification and validation testing.